Probiotech LLC is a clinical research organization. We provide solutions for phase I-IV clinical trials in Russian and CIS markets. We believe that because of the region's large patient population and highly qualified medical personnel we can create unique value for pharmaceutical and biotechnology companies going through clinical phases of drug development process. By improving enrollment into clinical trials and maintaining high level of retention we address the most common sources of clinical trial delays. The company operates in compliance with current FDA and ICH guidance on good clinical practice and the conduct of clinical trials (GCP).
Today, 90% of clinical trials are delayed because of unfulfilled enrollment and poor patient retention. At Probiotech we address these two challenges by working closely with medical centers and institutions that have access to target patient population and specialize in major therapeutic areas.
You can also contact us by visiting our contact page. Why wait? Call today to learn more. Novoclinica will deliver exceptional results for your next clinical trial.
When you partner with Probiotech you will get:
- Access to Russian medical centers and institutions
- Timely regulatory approval with Russian ministry of health and social development
- Effective clinical site monitoring
- Efficient clinical trial project management
- Global adverse event reporting
- Management of study supplies and samples
- Laboratory services
- Data management
- Medical writing, translation and other support services
Our vision for better medicine drives our commitment to success in working with sponsors, healthcare professionals, patients and local healthcare authorities. We believe that accelerating research in disease mechanisms and recent advancements in biological sciences will lead to better medicine. We see Probiotech being part of this process working closely with our partners and helping them bring better medicine to the patients.